Central Vly Cmty Bcp (CVCY) 15.34 $CVCY Central Valley

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Central Vly Cmty Bcp (CVCY) 15.34 $CVCY

Central Valley Community Bancorp Receives Regulatory Approvals to Acquire Sierra Vista Bank
Marketwire Canada - Wed Jul 27, 3:00PM CDT
FRESNO, CA--(Marketwired - Jul 27, 2016) - The Board of Directors of Central Valley Community Bancorp (Company) (NASDAQ: CVCY), the parent company of Central Valley Community Bank (Bank), announced today that required regulatory approval has been received by the Federal Deposit Insurance Corporation and California Department of Business Oversight authorizing Central Valley Community Bancorp to acquire Sierra Vista Bank. Final closing of the acquisition is dependent upon a special Sierra Vista Bank shareholder meeting scheduled for August 30, 2016, as well as certain closing conditions contained in the merger agreement.
CVCY: 15.34 (+0.39)

Central Valley Community Bancorp to Acquire Sierra Vista Bank
Marketwired - Fri Apr 29, 7:50AM CDT
Central Valley Community Bancorp (Company, together with its wholly owned subsidiary, Central Valley Community Bank (Bank)) (NASDAQ: CVCY), a bank holding company headquartered in Fresno, California, and Sierra Vista Bank (OTCBB: SVBA), headquartered in Folsom, California, jointly announced today that a definitive merger agreement has been signed by both parties. Under the terms of the agreement, Sierra Vista Bank, with three full service branches located in Folsom and Fair Oaks (Sacramento County), and Cameron Park (El Dorado County), will merge with Central Valley Community Bank. The transaction is subject to customary closing conditions, including regulatory approvals and Sierra Vista Bank shareholder approval. The Central Valley Community Bancorp and Sierra Vista Bank Boards of Directors have approved the transaction, which is expected to close in the fourth quarter of 2016.
CVCY: 15.34 (+0.39)

The Zacks Analyst Blog Highlights: Primo Water, Marine Products, Central Valley Community Bancorp and KCG Holdings
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 8:30AM CDT
The Zacks Analyst Blog Highlights: Primo Water, Marine Products, Central Valley Community Bancorp and KCG Holdings
KCG: 15.16 (+0.03), MPX: 9.05 (-0.08), PRMW: 11.78 (-0.20), CVCY: 15.34 (+0.39)

4 Breakout Stocks Under $15 for Explosive Returns
Zacks Equity Research - Zacks Investment Research - Tue Apr 26, 2:17PM CDT
When executed correctly, this strategy can yield lucrative gains, which explains its enduring popularity
MPX: 9.05 (-0.08), KCG: 15.16 (+0.03), PRMW: 11.78 (-0.20), CVCY: 15.34 (+0.39)

New Strong Buy Stocks for April 22nd
Zacks Equity Research - Zacks Investment Research - Fri Apr 22, 8:41AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
CCI: 97.50 (+0.47), BMI: 70.28 (+0.54), CVCY: 15.34 (+0.39), DIN: 82.18 (+0.81), ADTN: 18.19 (-0.01)

Central Valley Community Bancorp Declares Quarterly Cash Dividend
Marketwired - Thu Apr 21, 3:10PM CDT
The Board of Directors of Central Valley Community Bancorp (Company) (NASDAQ: CVCY), the parent company of Central Valley Community Bank (Bank), has declared a regular quarterly cash dividend of $0.06 per share on the Company's common stock. The dividend is payable on May 20, 2016 to shareholders of record as of May 5, 2016.
CVCY: 15.34 (+0.39)

Central Valley Community Bancorp posts 1Q profit
Automated Insights - Wed Apr 20, 3:09PM CDT
FRESNO, Calif. (AP) _ Central Valley Community Bancorp (CVCY) on Wednesday reported first-quarter net income of $3.4 million.
CVCY: 15.34 (+0.39)

Central Valley Community Bancorp Reports Earnings Results for the Quarter Ended March 31, 2016
Marketwired - Wed Apr 20, 3:00PM CDT
The Board of Directors of Central Valley Community Bancorp (Company) (NASDAQ: CVCY), the parent company of Central Valley Community Bank (Bank), reported today unaudited consolidated net income of $3,403,000, and diluted earnings per common share of $0.31 for the three months ended March 31, 2016, compared to $2,466,000 and $0.22 per diluted common share for the three months ended March 31, 2015.
CVCY: 15.34 (+0.39)

Why Central Valley (CVCY) Stock Might be a Great Pick
Zacks Equity Research - Zacks Investment Research - Fri Feb 05, 7:51AM CST
Central Valley is seeing solid earnings estimate revision activity and is a great company from a Zacks Industry Rank perspective
CVCY: 15.34 (+0.39)

Central Valley Community Bancorp Reports Earnings Results for the Year and Quarter Ended December 31, 2015
Marketwired - Tue Jan 26, 3:10PM CST
The Board of Directors of Central Valley Community Bancorp (Company) (NASDAQ: CVCY), the parent company of Central Valley Community Bank (Bank), reported today unaudited consolidated net income of $10,964,000, and diluted earnings per common share of $1.00 for the year ended December 31, 2015, compared to $5,294,000 and $0.48 per diluted common share for the year ended December 31, 2014.
CVCY: 15.34 (+0.39)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 60

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 24

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 11

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 150

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 94

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 31

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

BitGo Faces Securities Fraud Suit Amid Investor Losses

Updated Category News Views 69

BitGo's Legal Woes: A Deep Dive into the Allegations A lawsuit can shake up a company's foundations, and BitGo Holdings, Inc. (NYSE: BTGO) is feeling the heat right now. The focus of this busy investor morning isn’t some penny stock drama; we're talking about players in the digital asset game accused of pulling the wool over investors' eyes. Slap on those reading...

Continue Reading
Investors Alert: Deadline Approaches in Match Group Lawsuit

Updated Category News Views 141

Important Deadline Approaching for Match Group Investors Recently, there has been a notable reminder for investors concerning a class action lawsuit involving Match Group, Inc. (NASDAQ: MTCH). The law firm Glancy Prongay & Murray LLP has highlighted that all individuals who purchased shares in Match Group during the specified period should be aware of the upcoming...

Continue Reading
Leadership Transition at Coloplast A/S: New Era Begins

Updated Category News Views 937

Coloplast A/S Announces Leadership Change In a significant shift for Coloplast A/S, CEO Kristian Villumsen has officially stepped down. Today marks the start of a new chapter as the Board of Directors mobilizes Lars Rasmussen to serve as interim CEO while the search for a permanent replacement is conducted. Strategic Shift for the Future This change comes at an opportune...

Continue Reading
Johnson & Johnson's Strong Q3 Results Amid Market Declines

Updated Category News Views 109

Market Overview On a day marked by declining values, U.S. stocks experienced a noticeable downturn. The Nasdaq Composite index saw a drop of around 150 points, indicating a challenging market environment. As trading progressed, the Dow Jones Industrial Average slipped slightly, and the S&P 500 also followed suit, showing varied performance across sectors. Sector...

Continue Reading
Moroccanoil Expands Product Line at Ulta Beauty Nationwide

Updated Category News Views 204

Moroccanoil Expands Product Line at Ulta Beauty Nationwide Moroccanoil is thrilled to announce an exciting partnership with Ulta Beauty, the premier beauty retailer in the nation. This significant expansion reaffirms Moroccanoil's commitment to delivering high-quality beauty products to a wider audience while honoring its legacy rooted in the salon community. Launching at...

Continue Reading